A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, Phase II trial designed to evaluate the efficacy and
safety of PRO95780 when given as a single agent in patients with advanced chondrosarcoma. Up
to 90 patients with confirmed chondrosarcoma will be enrolled.